China's Generic Drug Market Still Competitive Despite Government Efforts To Promote Innovation
This article was originally published in PharmAsia News
Executive Summary
Chinese generic drugs are still fiercely competitive despite endeavors by China's State FDA in recent years to reduce the emphasis on generic drugs in the domestic pharmaceutical market, a Shanghai Brilliance Credit Rating & Investors Service analyst remarked